
Our medical experts are ready to answer your questions and guide you through your treatment options.
For couples in UAE considering PGT-A/PGT-M, the journey can feel complex. Questions about accessing advanced genetic testing for embryos, ensuring precision, and understanding the overall process are natural. Finding a trusted solution that aligns with personal and medical needs is often a primary concern for families.
Many international patients, including those from UAE, explore options beyond their borders for specialized medical care. India presents itself as a compelling destination, offering cutting-edge reproductive technologies and skilled specialists available in numerous well-equipped facilities across major cities nationwide.
India's medical infrastructure has earned global recognition for its advanced facilities and expert healthcare professionals. Numerous accredited hospitals and fertility clinics across the country provide high-standard PGT-A/PGT-M services, supported by experienced geneticists, embryologists, and a comprehensive care team.
India stands as a reliable and accessible choice for comprehensive genetic testing of embryos.
Preimplantation Genetic Testing (PGT) is an advanced reproductive technology performed during an In Vitro Fertilization (IVF) cycle. PGT-A (for Aneuploidy) involves screening embryos for chromosomal abnormalities before implantation. This helps identify embryos with the correct number of chromosomes, increasing the chances of a successful pregnancy and reducing the risk of miscarriage or a child born with conditions like Down syndrome. PGT-M (for Monogenic/Single Gene Defects) is specifically for couples known to be carriers of particular single-gene disorders. It allows them to select embryos unaffected by that genetic disease, preventing its transmission to their offspring. Both tests involve taking a tiny biopsy from an early embryo in the laboratory and analyzing its genetic material.
PGT-A (Preimplantation Genetic Testing for Aneuploidy): Screens embryos for an abnormal number of chromosomes (too many or too few).
PGT-M (Preimplantation Genetic Testing for Monogenic Disorders): Identifies specific single-gene defects, such as cystic fibrosis, thalassemia, or Huntington's disease, in embryos.
PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements): Used for couples where one partner carries a chromosomal structural rearrangement, like a translocation or inversion, to ensure balanced embryos are selected.
Embryo Biopsy: The delicate procedure of removing a few cells from the embryo for genetic analysis, typically performed at the blastocyst stage.
Advanced Genetic Sequencing: Utilizes sophisticated laboratory techniques to analyze the genetic material from the biopsied cells for accurate diagnosis.
The PGT-A/PGT-M process is seamlessly integrated within an in vitro fertilization (IVF) cycle, following a series of careful laboratory steps designed to ensure precision and embryo safety.
Fertility medications are administered to stimulate the ovaries to produce multiple eggs. Once mature, these eggs are gently retrieved from the ovaries under ultrasound guidance, a short outpatient procedure.
The retrieved eggs are fertilized with sperm in the laboratory, typically using IVF or Intracytoplasmic Sperm Injection (ICSI). The resulting embryos are then cultured for approximately 5-7 days until they reach the blastocyst stage.
A highly skilled embryologist performs a delicate trophectoderm biopsy, carefully removing a few cells from the outer layer of each blastocyst. This procedure is performed with extreme precision to minimize any potential impact on the embryo's development.
The biopsied cells are sent to a specialized genetics laboratory for analysis. PGT-A analyzes the cells for aneuploidies (abnormal chromosome numbers), while PGT-M focuses on detecting specific single-gene defects using advanced molecular techniques.
While awaiting genetic test results, the biopsied embryos are typically cryopreserved (frozen). Once the results are available, genetically healthy embryos are identified and selected for potential transfer.
In a subsequent cycle, one or more selected, healthy embryos are thawed and carefully transferred into the uterus. This aims for successful implantation and the initiation of a healthy pregnancy.
Recovery specifically from the PGT-A/PGT-M testing itself is minimal, as the main procedures involve laboratory work on embryos. The primary recovery considerations relate to the preceding IVF cycle. After egg retrieval, patients typically experience mild discomfort, bloating, or cramping for a few days, which can be managed with rest and prescribed pain relief. Following embryo transfer, a period of reduced physical activity and adherence to specific instructions from the fertility specialist is often advised. Emotional well-being and support are important during the waiting period for pregnancy results. Regular follow-up appointments with the fertility clinic are essential to monitor hormonal levels and check for early signs of pregnancy and overall health.
The success of PGT-A/PGT-M is measured by its ability to increase the likelihood of a healthy, live birth per embryo transfer, rather than just pregnancy rates. PGT-A can significantly improve implantation rates and reduce miscarriage rates, particularly for women over 35, often leading to a 60-70% live birth rate per euploid (chromosomally normal) embryo transferred. PGT-M provides a high degree of confidence in selecting embryos free from specific genetic disorders. Overall success, however, is influenced by multiple factors including maternal age, ovarian reserve, the quality of the embryos, the specific genetic condition being screened for, and the expertise of the fertility clinic and genetics laboratory. While PGT aims to optimize the chances of a healthy baby, it does not guarantee pregnancy.
The cost of PGT-A/PGT-M in India can vary significantly based on several key factors. These include the specific type of testing required (PGT-A, PGT-M, or PGT-SR), the number of embryos that need to be tested, the reputation and location of the chosen fertility clinic, the specialized charges for the genetic laboratory analysis, and whether the quoted price includes the associated IVF cycle costs or only the PGT component.
Generally, the cost for PGT-A/PGT-M testing per embryo in India ranges from approximately INR 30,000 to INR 60,000. This is typically in addition to the cost of the IVF cycle, which varies separately.
| City | Cost Range (INR) |
|---|---|
| Mumbai | 35,000 - 55,000 |
| Delhi | 30,000 - 50,000 |
| Bangalore | 38,000 - 58,000 |
| Chennai | 32,000 - 52,000 |
| Hyderabad | 30,000 - 50,000 |
| Kolkata | 28,000 - 48,000 |
| Ahmedabad | 29,000 - 49,000 |
| Country | Cost Range (USD, per embryo) |
|---|---|
| India | $400 - $750 |
| UAE | $1,200 - $2,500 |
| USA | $2,000 - $4,000 |
| UK | $1,500 - $3,000 |
| Thailand | $800 - $1,500 |
Connect with leading fertility specialists in India to discuss PGT-A/PGT-M and receive a personalized treatment plan.
Discover how specialized PGT-A/PGT-M treatment in India can support your family-building goals with expert care, advanced technology, and compassionate guidance.
Request a detailed consultation with India's top fertility clinics and receive a transparent cost estimate for your PGT-A/PGT-M treatment.
India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.
Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.
Get Personalized Medical Treatment Options From India's Top Hospitals. Our Medical Experts Are Ready To Assist You Every Step Of The Way.